Skip to content

Clinical trials

Completed Carcinoma, Hepatocellular trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Completed Country / region: South Korea Clear all

145 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20053
20066
20074
20086
200914
20107
201110
20126
201314
201410
201511
20166
20179
20187
20198
20205
202110
20222
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed145

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Hospital24
Bayer14
Samsung Medical Center10
Bristol-Myers Squibb7
GC Cell Corporation5
Hoffmann-La Roche5
Yonsei University5
Asan Medical Center4
AstraZeneca4
Eli Lilly and Company4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular145
Liver Neoplasms28
Neoplasms8
Carcinoma, Renal Cell5
Carcinoma, Non-Small-Cell Lung4
Cholangiocarcinoma4
Liver Diseases4
Vaccinia4
Carcinoma3
Liver Cirrhosis3

Trials

Showing 1 to 25 of 145. Each trial links to its page on Pharma Observatory.

45 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.